HomeTolvaptanTolvaptan + Potassium Supplements

Does Tolvaptan Interact with Potassium Supplements?

Tolvaptan and Potassium Supplements have a moderate drug interaction according to U.S. FDA drug labeling data. Concomitant use increases hyperkalemia risk by approximately 1-2%. Serum potassium levels should be monitored. The mechanism involves additive potassium retention. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Tolvaptan Class
Vasopressin V2 Receptor Antagonist
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Tolvaptan and Potassium Supplements occurs because additive potassium retention. Clinically, this means concomitant use increases hyperkalemia risk by approximately 1-2%. serum potassium levels should be monitored. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Tolvaptan and your doctor is considering prescribing Potassium Supplements (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tolvaptan(Tolvaptan)+💊 Potassium Supplements

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Vasopressin V2 Receptor Antagonist
Drug B class
Source
NLP:tolvaptan

What this means in plain English

Concomitant use increases hyperkalemia risk by approximately 1-2%. Serum potassium levels should be monitored.

What the FDA label says

"Additive potassium retention"

📖 Source: NLP:tolvaptan

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Tolvaptan and Potassium Supplements against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.